Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000064

Chief Scientific Officer acquired 13,629 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kishimoto Takashi Kei · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-07 Exercise or conversion : show line 1 in the form +13,629 $2.77 $37,752 177,778 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-07 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −13,629 0 D
Loading xslF345X03/wf-form4_162076464438216.xml…